2025-04-13 - Analysis Report
## Exxon Mobil Corp (XOM) Stock Review

**0. Key Figures Summary:**

* **Cumulative Return (XOM):** 17.85%
* **Cumulative Return (VOO):** 66.36%
* **Return Difference:** -48.5% (Relative Difference: 47.4%)
* **Current Price:** $103.14
* **5-Day Moving Average:** $102.52
* **20-Day Moving Average:** $112.32
* **60-Day Moving Average:** $110.16
* **RSI:** 32.75
* **PPO:** -1.65
* **Market Risk Indicator (MRI):** 0.47 (High Risk)
* **Expected Return (vs. S&P 500, long-term):** -22.5%


**1. Performance Comparison:**

Exxon Mobil Corp (XOM) is an American multinational oil and gas corporation.  Over the analyzed period, XOM significantly underperformed the S&P 500 (VOO), showing a cumulative return of 17.85% compared to VOO's 66.36%. This represents a difference of -48.5%, placing it at the 47.4th percentile of its historical range relative to VOO's performance.

The provided alpha and beta analysis shows inconsistent performance relative to the market (VOO). While some periods show positive alpha (outperformance), others indicate significant underperformance (negative alpha), highlighting the volatility and market sensitivity of XOM.  The beta values fluctuate, indicating variable sensitivity to market movements.  Capitalization (Cap(B)) shows significant increases over the years.


**2. Recent Price Movement:**

The recent price of $103.14 shows a $3.21 increase from the previous close, indicating a recent price jump.  However, this price is below both the 5-day, 20-day, and 60-day moving averages, suggesting a potential downward trend. The significant gap between the current price and the moving averages indicates a recent price spike potentially against a bearish overall trend.


**3. Technical Indicators and Expected Return:**

The RSI of 32.75 suggests the stock is currently in oversold territory.  The negative PPO (-1.65) further supports a bearish sentiment. The negative relative divergence (-10.3%) over the last 20 days confirms a recent short-term decline. The high Market Risk Indicator (MRI) of 0.47 signifies high risk.  The expected long-term (2+ years) return is estimated to be -22.5% relative to the S&P 500, indicating potential underperformance. The recent price jump needs further analysis to determine if it's a temporary bounce or the start of a new trend reversal.


**4. Recent Earnings Analysis:**

| Date       | EPS     | Expected EPS | Difference |
|------------|---------|-------------|------------|
| 2025-01-31 | 1.67    | 1.77        | -0.10       |
| 2024-11-01 | 1.92    | 1.88        | +0.04       |
| 2024-08-02 | 2.14    | 2.01        | +0.13       |
| 2024-04-26 | 2.06    | 2.20        | -0.14       |
| 2024-02-02 | 2.48    | 2.21        | +0.27       |

Earnings have been somewhat volatile, with both positive and negative surprises relative to expectations.  While some quarters exceeded expectations, others fell short, indicating inconsistency in earnings performance.


**5. Financial Information:**

**Revenue and Profitability:** Revenue has remained relatively stable around $80-$90 billion over the past few quarters. Profit margins have fluctuated between 21% and 23.5%, demonstrating consistent profitability but with some quarter-to-quarter variability.

**Capital and Profitability:** Equity shows a significant jump in Q1 2024, followed by a slight decrease in subsequent quarters.  ROE also fluctuates, showing a peak of 4% in Q1 2024 and a general downward trend thereafter.


**6. Overall Analysis:**

XOM has significantly underperformed the S&P 500 over the analyzed period, exhibiting high volatility and inconsistent performance relative to market benchmarks.  While recent price action shows a brief surge, technical indicators suggest bearish sentiment.  Earnings show volatility, and financial figures suggest stable but fluctuating profitability and equity. The high market risk and negative long-term expected return relative to the S&P 500 raise significant concerns.  Further investigation into the reasons for the recent price jump and a thorough analysis of the company's long-term strategy are crucial before making any investment decisions.  A long-term investment in XOM carries significant risk given its underperformance relative to the broader market and the negative outlook.
